Evidence map›Paper›PMID 24630992›Full record

ArticleCell reports2014

Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1.

Audrey Page, Valentina A Volchkova, Saint Patrick Reid, Mathieu Mateo, Audrey Bagnaud-Baule, Kirill Nemirov, Amy C Shurtleff, Philip Lawrence, Oliver Reynard, Michele Ottmann and 5 more

Open access · goldAbstract read
PubMed Publisher
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function.Advances in experimental medicine and biology · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Audrey PageMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Valentina A VolchkovaMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Saint Patrick ReidMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France; United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USA.
Mathieu MateoMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Audrey Bagnaud-BauleMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Kirill NemirovMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Amy C ShurtleffUnited States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USA.
Philip LawrenceMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Oliver ReynardMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Michele OttmannMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France.
Vincent LotteauIMAP team, CIRI, Lyon 69007, France.
Shyam S BiswalDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Rajesh K ThimmulappaDepartment of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Sina BavariUnited States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702-5011, USA.
Viktor E VolchkovMolecular Basis of Viral Pathogenicity, Centre International de Recherche en Infectologie (CIRI), INSERMU1111-CNRSUMR5308, Université de Lyon, Université Claude Bernard Lyon1, Ecole Normale Supérieure de Lyon, Lyon 69007, France. Electronic address: viktor.volchkov@inserm.fr.
Centre National de la Recherche Scientifique · FRÉcole Normale Supérieure de Lyon · FRInserm · FRJohns Hopkins University · USUnited States Army Medical Research Institute of Infectious Diseases · USUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marburg virus (MARV) has a high fatality rate in humans, causing hemorrhagic fever characterized by massive viral replication and dysregulated inflammation. Here, we demonstrate that VP24 of MARV binds Kelch-like ECH-associated protein 1 (Keap1), a negative regulator of nuclear transcription factor erythroid-derived 2 (Nrf2). Binding of VP24 to Keap1 Kelch domain releases Nrf2 from Keap1-mediated inhibition promoting persistent activation of a panoply of cytoprotective genes implicated in cellular responses to oxidative stress and regulation of inflammatory responses. Increased expression of Nrf2-dependent genes was demonstrated both during MARV infection and upon ectopic expression of MARV VP24. We also show that Nrf2-deficient mice can control MARV infection when compared to lethal infection in wild-type animals, indicating that Nrf2 is critical for MARV infection. We conclude that VP24-driven activation of the Nrf2-dependent pathway is likely to contribute to dysregulation of host antiviral inflammatory responses and that it ensures survival of MARV-infected cells despite these responses.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCytoskeletal ProteinsHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1MarburgvirusMiceMice, Inbred C57BLNF-E2-Related Factor 2Protein BindingSignal TransductionTransfectionAdaptor Proteins, Signal TransducingCytoskeletal ProteinsIntracellular Signaling Peptides and ProteinsKEAP1 protein, humanKeap1 protein, mouseKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2

Identifiers

PMID24630992
OpenAlexW2145812375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.